Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Samuraciclib hydrochloride in Advanced Pancreatic Ductal Adenocarcinoma: NCT07645651 Clinical Landscape Report 2026
9 min read
Samuraciclib hydrochloride in Advanced Pancreatic Ductal Adenocarcinoma: NCT07645651 Clinical Landscape Report 2026
18 September 2026
NCT07645651 clinical landscape for Advanced Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →
Levodopa hydrate in Parkinson Disease: NCT07647913 Clinical Landscape Report 2026
9 min read
Levodopa hydrate in Parkinson Disease: NCT07647913 Clinical Landscape Report 2026
18 September 2026
NCT07647913 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nolgileucel in Recurrent ovarian cancer: NCT07651124 Clinical Landscape Report 2026
9 min read
Nolgileucel in Recurrent ovarian cancer: NCT07651124 Clinical Landscape Report 2026
18 September 2026
NCT07651124 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CLSP-5282 in Locally Advanced Malignant Solid Neoplasm: NCT07650357 Clinical Landscape Report 2026
9 min read
CLSP-5282 in Locally Advanced Malignant Solid Neoplasm: NCT07650357 Clinical Landscape Report 2026
18 September 2026
NCT07650357 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
Read →
ES502 in Pancreatic Cancer: NCT07649928 Clinical Landscape Report 2026
9 min read
ES502 in Pancreatic Cancer: NCT07649928 Clinical Landscape Report 2026
18 September 2026
NCT07649928 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Evexomostat in Prostate Cancer, Familial: ACTRN12626000736347 Clinical Landscape Report 2026
9 min read
Evexomostat in Prostate Cancer, Familial: ACTRN12626000736347 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000736347 clinical landscape for Prostate Cancer, Familial: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
[68Ga]Ga-A9-6217 (Alpha-9 Oncology USA Inc.) in Breast Cancer: NCT07661641 Clinical Landscape Report 2026
9 min read
[68Ga]Ga-A9-6217 (Alpha-9 Oncology USA Inc.) in Breast Cancer: NCT07661641 Clinical Landscape Report 2026
18 September 2026
NCT07661641 clinical landscape for Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
177Lu-PSMA-VG-01 in PSMA-Positive Castration-Resistant Prostatic Cancer: NCT07660211 Clinical Landscape Report 2026
9 min read
177Lu-PSMA-VG-01 in PSMA-Positive Castration-Resistant Prostatic Cancer: NCT07660211 Clinical Landscape Report 2026
18 September 2026
NCT07660211 clinical landscape for PSMA-Positive Castration-Resistant Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →
Probucol in Parkinson Disease: ACTRN12626000740392 Clinical Landscape Report 2026
9 min read
Probucol in Parkinson Disease: ACTRN12626000740392 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000740392 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Sulfamethoxazole/Trimethoprim in Pulmonary Disease, Chronic Obstructive: NCT07665359 Clinical Landscape Report 2026
9 min read
Sulfamethoxazole/Trimethoprim in Pulmonary Disease, Chronic Obstructive: NCT07665359 Clinical Landscape Report 2026
18 September 2026
NCT07665359 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Levodopa hydrate in Parkinson Disease: ACTRN12626000769381 Clinical Landscape Report 2026
9 min read
Levodopa hydrate in Parkinson Disease: ACTRN12626000769381 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000769381 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ontunisertib in Crohn Disease: NCT07672574 Clinical Landscape Report 2026
9 min read
Ontunisertib in Crohn Disease: NCT07672574 Clinical Landscape Report 2026
18 September 2026
NCT07672574 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →